甾体激素预处理在辅助生殖技术中的应用  

Steroid hormone pretreatments in assisted reproductive technology

作　　者：张巧利[1] 贾婵维[1] 李颖[1] 梁毓[1] 马延敏[1] 张军[1] 王树玉[1] Zhang Qiaoli;Jia Chanwei;Li Ying;Liang Yu;Ma Yanmin;Zhang Jun;Wang Shuyu(Department of Human Reproductive Medicine,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100026,China)

机构地区：[1]首都医科大学附属北京妇产医院生殖医学中心,100026

出　　处：《中华生殖与避孕杂志》2018年第5期427-431,共5页Chinese Journal of Reproduction and Contraception

基　　金：国家自然科学基金资助项目(81302441);首都医科大学附属北京妇产医院中青年学科骨干培养专项(fcyy201606)~~

摘　　要：卵巢储备功能下降(DOR)及卵巢低反应(POR)是辅助生殖中常遇到的棘手问题,常导致不良的助孕结局。人们尝试探索不同的方法改善卵巢储备功能及卵巢的反应性,甾体激素最为常用。本文就常用的雄激素、口服避孕药及雌激素的预处理在辅助生殖技术中的应用做一综述。The diminished ovarian reserve（DOR） and poor ovarian response（POR） are the thorny issues in the assisted reproductive technology（ART）, which often lead to adverse assisted reproduction outcome. Many different ways are explored to improve ovarian function and promote the controlled ovarian stimulation. The pretreatment of steroid hormones is the most commonly used. The article reviewed the pretreatment including androgens, oral contraceptive and estradiol in ART.

关 键 词：辅助生殖 预处理 雄激素 口服避孕药 雌激素 

分 类 号：R714.8[医药卫生—妇产科学]